Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda - Newsinferno.com

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland ...

Clinical trial concludes diabetes control in teens is very difficult to maintain - Examiner

According to CBS News, the author of the study, Dr. Phil Zeitler, head of endocrinology at University of Colorado Children's Hospital, stated that doctors wouldn't recommend this combination of drug therapy because Avandia has since been linked ...

Diabetes: Pioglitazone and Rosiglitazone may be related to fracture risk - Xagena Medical News

Two drugs in this category, Pioglitazone ( Actos ) and Rosiglitazone, ( Avandia ) account for 21 percent of oral diabetes medications prescribed in the United States and 5 percent of those in Europe. Recent studies have suggested that these therapies may ...

Two-Drug Therapy Helped Kids With Type 2 Diabetes - YAHOO!

SUNDAY, April 29 (HealthDay News) -- Children with type 2 diabetes may achieve better blood sugar control with a combination of two drugs, metformin and Avandia, than with metformin alone, a new study suggests. However, Avandia (rosiglitazone) was recently ...

Teens with diabetes have trouble managing it, study says - Los Angeles Times

All had their blood sugar normalized with metformin, then received one of three treatments to try to maintain that control: metformin alone, metformin plus diet and exercise counseling, or metformin plus a second drug, Avandia. After nearly four ...

FDA Needs Post-Market Drug Plan, Institute Says - NationalJournal.com

One piece advice from the committee of experts: start these so-called post-market studies sooner. A good example is the diabetes drug Avandia, which raised cholesterol in some patients. “There was a hint in the early data about Avandia that it ...

Clara Barton Founded The American Red Cross - digtriad.com

The Food and Drug Administration issued a safety alert for the diabetes drug Avandia, marketed by GlaxoSmithKline, which disputed a report saying it was linked to a greater risk of heart attack. One year ago: The apocalypse did not arrive, despite the ...

Can Social Networks Cure Disease? Part I - Huffington Post

We ate ourselves into this problem, and we have to eat ourselves out of it. High cholesterol is not a statin deficiency, and diabetes is not an Avandia deficiency. It is not doing the same things better. What we are doing is not really working. It is just ...

This Day in History - San Mateo Daily Journal

The Food and Drug Administration issued a safety alert for the diabetes drug Avandia, marketed by GlaxoSmithKline, which disputed a report saying it was linked to a greater risk of heart attack. One year ago: The apocalypse did not arrive, despite the ...

Alzheimer’s Research Effort Seeks New Treatments by 2025 (Update 1) - Bloomberg

The approach didn’t improve other measures of mental function. GlaxoSmithKline Plc (GSK)’s Avandia, once the biggest selling diabetes drug, failed to benefit Alzheimer’s disease patients in a 2009 study. A 2008 study underscored the ...